Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in [...]
Lori Saslow, MS; David K.B. Li, MD; June Halper, APN-C; Brenda Banwell, MD; Frederik Barkhof, MD, PhD; Laura Barlow, RTR, RMTR; Kathleen [...]
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]
This guideline was developed by a group of multiple sclerosis (MS) specialists, convened by the Consortium of Multiple Sclerosis Centers [...]
Several organizations have expressed interest and published guidelines or consensus statements emphasizing the need for palliative care for [...]
The American Academy of Neurology has completed and posted a Patient Summary and Clinician Summary of an Evidence-based [...]
In this program, people living with or affected by MS will have the opportunity to network with one another and to learn from leading MS [...]
